Vericel VCEL
NASDAQ VCEL
$40.19 -0.28 (-0.69%)
As of: Sep 4, 2026 · 3:59 PM EDT

Vericel (VCEL) Change in Inventory (2014 - 2026)

Vericel (VCEL) posted Change in Inventory of $183000.0 for Q2 2026, down 81.02% sequentially from $964000.0 in Q1 2026, and up 166.55% YoY from $68656.2 in Q2 2025.

Analysis

Vericel (VCEL) Change in Inventory (2014 - 2026) Analysis & Trends

Vericel has reported Change in Inventory for 13 years, with the latest figure at $183000.0 in Q2 2026.

  • Quarterly Change in Inventory rose 166.55% year-over-year to $183000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.9 million (up 50.15% YoY) and the FY2025 annual result came in at $1.2 million, down 71.3% from the prior year.
  • Change in Inventory fell to $183000.0 in Q2 2026 per VCEL's latest filing, from $964000.0 in the prior quarter.
  • Over five years, Change in Inventory peaked at $1.6 million in Q4 2024 and troughed at -$1.5 million in Q2 2023.
  • A 5-year average of $353833.3 and a median of $468000.0 in 2023 frame the typical range for Change in Inventory.
  • The widest YoY moves for Change in Inventory: up 700.0% in 2022, down 330.75% in 2022.
  • Over 5 years, Change in Inventory stood at -$743000.0 in 2022, then jumped by 162.72% to $466000.0 in 2023, then jumped by 247.0% to $1.6 million in 2024, then slumped by 72.29% to $448000.0 in 2025, then slumped by 59.15% to $183000.0 in 2026.
  • According to Business Quant data, Change in Inventory over the past three periods registered $183000.0, $964000.0, and $448000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 27.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 28.20 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 132.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 47.15 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -280,000.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 12.97 Mn
10 Vericel 2.05 Bn 1.89 Bn 56.40 Mn 183,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 183,000.00
Mar 31, 2026 964,000.00
Dec 31, 2025 448,000.00
Sep 30, 2025 1.32 Mn
Jun 30, 2025 -275,000.00
Mar 31, 2025 -267,000.00
Dec 31, 2024 1.62 Mn
Sep 30, 2024 869,000.00
Jun 30, 2024 1.33 Mn
Mar 31, 2024 470,000.00
Dec 31, 2023 466,000.00
Sep 30, 2023 -1.26 Mn
Jun 30, 2023 -1.49 Mn
Mar 31, 2023 -616,000.00
Dec 31, 2022 -743,000.00
Sep 30, 2022 800,000.00
Jun 30, 2022 1.54 Mn
Mar 31, 2022 1.00 Mn
Dec 31, 2021 322,000.00
Sep 30, 2021 100,000.00